Metformin attenuates paracetamol-induced hepatorenal damage and oxidative stress in rats
Tropical Journal of Pharmaceutical Research · 30.04.2026 · 25 (4) · 453-460
DOI: 10.4314/tjpr.v25i4.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tropical Journal of Pharmaceutical Research, online erschienen am 30.04.2026. Verfasst von Kenneth Anachuna und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To evaluate the protective effect of metformin against hepatorenal damage induced by acute paracetamol toxicity in rats.
Methods
Twenty Wistar rats of both sexes were divided into four groups (n = 5 each). Groups 1 and 2 received distilled water orally, while groups 3 and 4 received metformin (500 mg/kg) and silymarin (100 mg/kg), respectively, orally once daily for six days. On day 7, paracetamol (3 g/kg) was administered orally to groups 2-4 to induce toxicity. After 24 h, blood samples were collected for the biochemical assessment of liver enzymes (alanine transaminase - ALT, aspartate transaminase - AST, alkaline phosphatase - ALP, and lactate dehydrogenase - LDH), kidney markers (urea and creatinine), and oxidative stress parameters (superoxide dismutase - SOD, catalase - CAT, glutathione - GSH, glutathione peroxidase - GPx, malondialdehyde - MDA, and nitrite). Data were analyzed using one-way ANOVA followed by Tukey's post-hoc test.
Results
Paracetamol administration significantly (p < 0.05) elevated liver enzymes, total bilirubin, urea, creatinine, MDA, and nitrite concentrations, while significantly (p < 0.05) reducing antioxidant enzymes and albumin as seen in group 2 compared to group 1. Pretreatment with metformin markedly (p < 0.05) attenuated these alterations, restored liver and kidney biomarkers, and improved antioxidant status. These effects were comparable to those of the silymarin treatment group.
Conclusion
Metformin demonstrates significant protective effects against paracetamol-induced hepatorenal toxicity, likely through antioxidant enhancement and reduction of oxidative stress, thus supporting its potential for repurposing to mitigate drug-induced organ injury.
Zitieren
APA
Anachuna, K., Moke, E., Chinwuba, P., Jaiyeoba-Ojigho, E., Okafo, S., & Isibor, N. (2026). Metformin attenuates paracetamol-induced hepatorenal damage and oxidative stress in rats. Tropical Journal of Pharmaceutical Research, 25(4), 453-460. https://doi.org/10.4314/tjpr.v25i4.2
Vancouver
Anachuna K, Moke E, Chinwuba P, Jaiyeoba-Ojigho E, Okafo S, Isibor N. Metformin attenuates paracetamol-induced hepatorenal damage and oxidative stress in rats. Tropical Journal of Pharmaceutical Research. 2026;25(4):453-460. doi:10.4314/tjpr.v25i4.2
BibTeX
@article{Anachuna2026,
author = {Anachuna, Kenneth and Moke, Emuesiri and Chinwuba, Paul and Jaiyeoba-Ojigho, Efe and Okafo, Sinodukoo and Isibor, Nkechi},
title = {Metformin attenuates paracetamol-induced hepatorenal damage and oxidative stress in rats},
journal = {Tropical Journal of Pharmaceutical Research},
year = {2026},
volume = {25},
number = {4},
pages = {453--460},
doi = {10.4314/tjpr.v25i4.2}
}
EUVIMED